je.st
news
Federal Circuit Keeps Sandoz Biosimilar Off the Market for Now
2015-05-08 04:19:44| Biotech - Topix.net
The Federal Circuit is set to hear oral arguments in Amgen v. Sandoz on June 3, but in the meantime has granted Amgen's motion for a preliminary injunction to keep Sandoz' biosimilar version of Neupogen off the market until it renders its decision.
Tags: now
market
federal
circuit
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||